These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14456770)

  • 1. [On light optical demonstration of complement fixation in the Masugi kidney with labelled anticomplement].
    KLEIN P
    Allerg Asthmaforsch; 1961; 4():306-8. PubMed ID: 14456770
    [No Abstract]   [Full Text] [Related]  

  • 2. [Histological demonstration of liverspecific antigens and their disappearance in hepatoma with the aid of fluorescein-labelled anticomplement].
    FISCHER C; WEILER E
    Z Krebsforsch; 1962; 64():441-7. PubMed ID: 13893112
    [No Abstract]   [Full Text] [Related]  

  • 3. [The demonstration of fixed complement with marked anticomplement].
    KLEIN P; BURKHOLDER P
    Schweiz Z Pathol Bakteriol; 1959; 22():729-31. PubMed ID: 14409699
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of FUT-175 on rat experimental nephritis. I. Rat Masugi nephritis].
    Kawasaki K; Yaoita E; Yamamoto T; Kihara I
    Nihon Jinzo Gakkai Shi; 1984 Feb; 26(2):151-5. PubMed ID: 6748333
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the specificity of the demonstration of bound complement with fluoresceinlabelled anticomplement].
    MUELLER F; GIESE G; RICKEN D
    Z Hyg Infektionskr; 1961; 147():434-46. PubMed ID: 13773480
    [No Abstract]   [Full Text] [Related]  

  • 6. [Histo-serological studies with fluorescein-labeled anticomplement. Demonstration of complement-binding substances in amyloid].
    VOGT A; KOCHEM HG
    Z Zellforsch Mikrosk Anat; 1960; 52():640-52. PubMed ID: 13781854
    [No Abstract]   [Full Text] [Related]  

  • 7. [A simple method for removing anticomplement activity of sera].
    WIGAND R
    Z Immun exp ther; 1962 Dec; 124():368-9. PubMed ID: 14000599
    [No Abstract]   [Full Text] [Related]  

  • 8. [Masugi nephritis and serum complement in rat; species-bound differences in pathogenetic mechanism of the Masugi nephritis in rat and in rabbit].
    PFEIFFER EF; SCHOFFLING K; BRUCH HE; SPIELMANN W
    Z Gesamte Exp Med; 1954; 122(5):446-64. PubMed ID: 13170022
    [No Abstract]   [Full Text] [Related]  

  • 9. Expansion of Anticomplement Therapy Indications from Rare Genetic Disorders to Common Kidney Diseases.
    Miwa T; Sato S; Golla M; Song WC
    Annu Rev Med; 2024 Jan; 75():189-204. PubMed ID: 37669567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Method for determining the anticomplement activity in immunoglobulin preparations].
    Kiseleva IA; Timofeeva GV
    Gematol Transfuziol; 1986 Apr; 31(4):54-7. PubMed ID: 3519357
    [No Abstract]   [Full Text] [Related]  

  • 11. [RESEARCH ON THE RELATION BETWEEN COMPLEMENT AND ANTICOMPLEMENT ACTIVITY IN CHILDREN].
    CICCIMARRA F
    Pediatria (Napoli); 1963; 71():660-8. PubMed ID: 14051038
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the inhibitive effect of some substances on the properdin system-comparison with their anticomplement action].
    RYBAK M; PETAKOVA M; KOCI J
    Cesk Epidemiol Mikrobiol Imunol; 1962 Jan; 11():58-61. PubMed ID: 14495597
    [No Abstract]   [Full Text] [Related]  

  • 13. [ANTICOMPLEMENT EFFECTS OF SERUM AND GAMMA-GLOBULIN].
    SCHIERZ G
    Z Immunitats Allergieforsch; 1964 Oct; 127():418-27. PubMed ID: 14323406
    [No Abstract]   [Full Text] [Related]  

  • 14. [Circulating immune complexes and the complement level in children with acute pneumonia].
    Popova OIa; Rodshteĭn OA; Kositskaia LS; Shteĭnlukht PL
    Ter Arkh; 1985; 57(5):42-5. PubMed ID: 2410992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
    Bomback AS; Appel GB; Gipson DS; Hladunewich MA; Lafayette R; Nester CM; Parikh SV; Smith RJH; Trachtman H; Heeger PS; Ram S; Rovin BH; Ali S; Arceneaux N; Ashoor I; Bailey-Wickins L; Barratt J; Beck L; Cattran DC; Cravedi P; Erkan E; Fervenza F; Frazer-Abel AA; Fremeaux-Bacchi V; Fuller L; Gbadegesin R; Hogan JJ; Kiryluk K; le Quintrec-Donnette M; Licht C; Mahan JD; Pickering MC; Quigg R; Rheault M; Ronco P; Sarwal MM; Sethna C; Spino C; Stegall M; Vivarelli M; Feldman DL; Thurman JM
    Am J Kidney Dis; 2022 Apr; 79(4):570-581. PubMed ID: 34571062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticomplement activity in human aqueous humor.
    Zheng XB; Peng Q; Sha L
    Ophthalmic Res; 1994; 26(4):200-1. PubMed ID: 7808728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticomplement activity of the serum of subjects with nasal ozena].
    CORBETTA L
    Arch Ital Otol Rinol Laringol; 1962; 73():639-45. PubMed ID: 14022965
    [No Abstract]   [Full Text] [Related]  

  • 18. [Complement determination and paper electrophoretic studies of the rat serum in Masugi nephritis].
    Protsch G
    Acta Biol Med Ger; 1967; 18(2):251-7. PubMed ID: 5586806
    [No Abstract]   [Full Text] [Related]  

  • 19. Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats. Terminal complement components are not the sole mediators of proteinuria.
    Hara M; Batsford SR; Mihatsch MJ; Bitter-Suermann D; Vogt A
    Lab Invest; 1991 Aug; 65(2):168-79. PubMed ID: 1881120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Masugi hetero-immune nephritis in rats. 3. Histological and ultrastructural study. (Attempt of comparison with protein data)].
    Hartmann L; Bariéty J; Nebut M; Lagrue G
    Ann Biol Clin (Paris); 1969; 27(7):437-50. PubMed ID: 4187677
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.